N-(4-guanidinylbutyl)-N-(3-guanidinylpropyl)amine sesquisulfate dihydrate | 82958-68-7

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 有机硫酸及其衍生物
• 英文名称: N-(4-guanidinylbutyl)-N-(3-guanidinylpropyl)amine sesquisulfate dihydrate
• 英文别名: N-(4-guanidinylbutyl)-N-3-(guanidylpropyl)amine sesquisulfate；2-[3-({4-[(Diaminomethylidene)amino]butyl}amino)propyl]guanidine sulfate(1:1)；2-[3-[4-(diaminomethylideneamino)butylamino]propyl]guanidine;sulfuric acid
• CAS: 82958-68-7
• 化学式: C₉H₂₃N₇*H₂O₄S
• 分子量: 376.448
• InChiKey: VFTOAYKDOXUZTG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -2.36
• 重原子数：
  21
• 可旋转键数：
  9
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.78
• 拓扑面积：
  224
• 氢给体数：
  7
• 氢受体数：
  7

反应信息

• 作为反应物：
  描述：

  N-(4-guanidinylbutyl)-N-(3-guanidinylpropyl)amine sesquisulfate dihydrate 在 barium(II) hydroxide 作用下， 以 水 为溶剂， 生成 2-[4-[3-(二氨基亚甲基氨基)丙基氨基]丁基]胍
  参考文献：
  名称：

  [EN] METHODS AND COMPOSITIONS COMPRISING GUANIDINES FOR TREATING BIOFILMS
  [FR] MÉTHODES ET COMPOSITIONS COMPRENANT DES GUANIDINES DESTINÉS AU TRAITEMENT DE BIOFILMS

  摘要：

  描述了使用胍类物质治疗或减少生物膜、治疗与生物膜有关的疾病、促使生物膜解体以及预防生物膜形成的方法。

  公开号：

  WO2014078801A1
• 作为产物：
  描述：

  亚精胺 、 S-甲基异硫脲硫酸盐 在 ammonium hydroxide 、 水 作用下， 反应 24.0h， 以47%的产率得到N-(4-guanidinylbutyl)-N-(3-guanidinylpropyl)amine sesquisulfate dihydrate
  参考文献：
  名称：

  Protecting-group strategies for the synthesis of N  4-substituted and N  1,N  8-disubstituted spermidines, exemplified by hirudonine

  摘要：

  本文描述了制备多胺衍生物1,4-二氨基丁烷（腐胺）和N-（3-氨基丙基）-1,4-二氨基丁烷（精胺）的方法，其中特定的氨基被修饰为胍基等官能团。在这些多胺中，特定的氨基被保护成N-三氟乙酰基和N-4-叠氮苄氧羰基衍生物，并分别使用甲醇氨和二硫苏糖醇-三乙胺选择性地脱去保护。通过改进的方法引入胍基官能团，其中氨基与3,5-二甲基-N-硝基-1H-吡唑-1-羧酰亚胺在甲醇中反应生成硝基胍衍生物，然后通过催化转移氢化除去硝基。该方法以开发高效的制备路线至胍氨酸和蛭素为例。保护/去保护序列的完整性通过其硫酸盐的晶体结构分析得到了证实。评估了选定化合物对大鼠肺细胞摄取腐胺的影响，并显示N-4-（4-叠氮苄氧羰基）精胺是最好的抑制剂（Ki = 3.4 µM）。

  DOI：

  10.1039/a806355i

文献信息

• Synthesis and Activity of Biomimetic Biofilm Disruptors
  作者：Thomas Böttcher、Ilana Kolodkin-Gal、Roberto Kolter、Richard Losick、Jon Clardy

  DOI：10.1021/ja3120955

  日期：2013.2.27

  Biofilms are often associated with human bacterial infections, and the natural tolerance of biofilms to antibiotics challenges treatment. Compounds with anti-biofilm activity could become useful adjuncts to antibiotic therapy. We used norspermidine, a natural trigger for biofilm disassembly in the developmental cycle of Bacillus subtilis, to develop guanidine and biguanide compounds with up to 20-fold increased potency in preventing biofilm formation and breaking down existing biofilms. These compounds also were active against pathogenic Staphylococcus aureus. An integrated approach involving structure activity relationships, protonation constants, and crystal structure data on a focused synthetic library revealed that precise spacing of positively charged groups and the total charge at physiological pH distinguish potent biofilm inhibitors.
• Protecting-group strategies for the synthesis of N  4-substituted and N  1,N  8-disubstituted spermidines, exemplified by hirudonine
  作者：Bernard T. Golding、Andrew Mitchinson、William Clegg、Mark R. J. Elsegood、Roger J. Griffin

  DOI：10.1039/a806355i

  日期：——

  Methods are described for the preparation of derivatives of the polyamines 1,4-diaminobutane (putrescine) and N-(3-aminopropyl)-1,4-diaminobutane (spermidine) in which a particular amino group is modified with, e.g., a guanidino function. Specific amino groups in these polyamines were protected as N-trifluoroacetyl and N-4-azidobenzyloxycarbonyl derivatives, which were unmasked chemoselectively using methanolic ammonia and dithiothreitol–triethylamine, respectively. Guanidino functions were introduced by an improved procedure in which an amino group was treated with 3,5-dimethyl-N-nitro-1H-pyrazole-1-carboximidamide in methanol to give a nitroguanidine derivative, from which the nitro group was removed by catalytic transfer hydrogenation. The methodology is exemplified by the development of efficient preparative routes to agmatine and hirudonine. The integrity of the sequence of protection/deprotection leading to hirudonine was confirmed by a crystal-structure analysis of its sulfate. The effect of selected compounds on the uptake of putrescine into rat lung cells was determined and showed that N 4-(4-azidobenzyloxycarbonyl)spermidine was the best inhibitor (Ki = 3.4 µM).

  本文描述了制备多胺衍生物1,4-二氨基丁烷（腐胺）和N-（3-氨基丙基）-1,4-二氨基丁烷（精胺）的方法，其中特定的氨基被修饰为胍基等官能团。在这些多胺中，特定的氨基被保护成N-三氟乙酰基和N-4-叠氮苄氧羰基衍生物，并分别使用甲醇氨和二硫苏糖醇-三乙胺选择性地脱去保护。通过改进的方法引入胍基官能团，其中氨基与3,5-二甲基-N-硝基-1H-吡唑-1-羧酰亚胺在甲醇中反应生成硝基胍衍生物，然后通过催化转移氢化除去硝基。该方法以开发高效的制备路线至胍氨酸和蛭素为例。保护/去保护序列的完整性通过其硫酸盐的晶体结构分析得到了证实。评估了选定化合物对大鼠肺细胞摄取腐胺的影响，并显示N-4-（4-叠氮苄氧羰基）精胺是最好的抑制剂（Ki = 3.4 µM）。
• [EN] METHODS AND COMPOSITIONS COMPRISING GUANIDINES FOR TREATING BIOFILMS<br/>[FR] MÉTHODES ET COMPOSITIONS COMPRENANT DES GUANIDINES DESTINÉS AU TRAITEMENT DE BIOFILMS
  申请人：HARVARD COLLEGE

  公开号：WO2014078801A1

  公开（公告）日：2014-05-22

  Methods of treating or reducing biofilms, treating a biofilm-related disorder, triggering biofilm disassembly, and preventing biofilm formation using guanidines is described.

  描述了使用胍类物质治疗或减少生物膜、治疗与生物膜有关的疾病、促使生物膜解体以及预防生物膜形成的方法。